PMID- 36204426 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20221009 IS - 1735-4668 (Print) IS - 2008-0700 (Electronic) IS - 1735-4668 (Linking) VI - 16 IP - 3 DP - 2022 Summer TI - Infantile Neuroaxonal Dystrophy in Two Cases: Siblings with Different Presentations. PG - 193-198 LID - 10.22037/ijcn.v16i2.30864 [doi] AB - Infantile neuroaxonal dystrophy (INAD) is a rare recessive neurodegenerative disorder manifested by symptoms like hypotonia, extrapyramidal signs, spastic tetraplegia, vision problems, cerebellar ataxia, cognitive complications, and dementia before the age of three. Various reports evaluated the relationship between the incidence of INAD and different mutations in the PLA2G6 gene. We described cases of two children with INAD whose diagnoses were challenging due to misleading findings and a mutation in the C.2370 T>G (p. Y790X) in the PLA2G6 gene based on NM_001349864, which has been reported previously. CI - (c) 2022 The Authors. FAU - Ansari, Behnaz AU - Ansari B AD - Neurologist, Isfahan Neuroscience Research Center, Al-Zahra Hospital Research Institute, Department of Pediatric Neurology, Isfahan University of Medical Science, Isfahan, Iran. FAU - Nasiri, Jafar AU - Nasiri J AD - Professor of Neurology, Department of Pediatric Neurology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. FAU - Namazi, Hamide AU - Namazi H AD - Medical Genetics, Medical Genetics Laboratory, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran. FAU - Sedghi, Maryam AU - Sedghi M AD - Medical Genetics, Medical Genetics Laboratory, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran. FAU - Afzali, Mahdieh AU - Afzali M AD - Neurologist, Department of Neurologist, School of Medicine, Yas Hospital, Tehran University of Medical Sciences Tehran, Iran. LA - eng PT - Case Reports DEP - 20220716 PL - Iran TA - Iran J Child Neurol JT - Iranian journal of child neurology JID - 101463836 PMC - PMC9531199 OTO - NOTNLM OT - Glycerophospholipids OT - Group VI Phospholipases A2 OT - Muscle Hypotonia OT - Neurodegenerative Diseases COIS- The authors declare no conflicts of interest. EDAT- 2022/10/08 06:00 MHDA- 2022/10/08 06:01 PMCR- 2022/10/01 CRDT- 2022/10/07 02:53 PHST- 2020/06/11 00:00 [received] PHST- 2021/05/10 00:00 [accepted] PHST- 2022/10/07 02:53 [entrez] PHST- 2022/10/08 06:00 [pubmed] PHST- 2022/10/08 06:01 [medline] PHST- 2022/10/01 00:00 [pmc-release] AID - 10.22037/ijcn.v16i2.30864 [doi] PST - ppublish SO - Iran J Child Neurol. 2022 Summer;16(3):193-198. doi: 10.22037/ijcn.v16i2.30864. Epub 2022 Jul 16.